Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2005
03/16/2005CN1596309A Recombinant DNA encoding the major allergen of plantago lanceolata pollen, PLA L 1, and applications thereof
03/16/2005CN1596308A Methods and compositions for degrading nitrogen-containing compounds
03/16/2005CN1596306A Methods of screening for introduction of DNA into a target cell
03/16/2005CN1596301A Gamma-glutamylcystein-producing yeast and method of screening the same
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596267A Genes coding for regulatory proteins
03/16/2005CN1596266A Specific binding agents of human angiopoietin-2
03/16/2005CN1594591A Method for screening aerobic denitrifying bacteria
03/16/2005CN1594582A Process for preparing human apolipoprotein A-I
03/16/2005CN1594571A Paraquat resistance gene and a vascular tissue- and trichome-specific promotor
03/16/2005CN1594552A Protein conformational disease cell model and its use
03/16/2005CN1594551A Micro-ecological bacteria preparation for rebuilding aquaculture water environment and method for preparing same
03/16/2005CN1594550A Method for degradation of linear alkyl benzene sodium sulfonate agrobacterium conn and treatment of water
03/16/2005CN1594549A Preparation of pseudomonas stutzeri strain and its use in desulfurization of organic sulfur compounds
03/16/2005CN1594548A Preparation of agrobacterium tumefaciens strain and its use in desulfurization of organic sulfur compounds
03/16/2005CN1594547A construction of HD34-1 strain and method for making alcohol-free beer with HD34-1 strain as ferment strain
03/16/2005CN1594546A Menadione adding method for increasing yield of catalase prepared by microbiological method
03/16/2005CN1594545A Method for promoting and inducing generation and accumulation of ginseng secondary metabolite
03/16/2005CN1594544A Method for producing trichoderma chlamydosporium
03/16/2005CN1594543A Laccase and gene encoding same and engineering bacterium
03/16/2005CN1594542A Aspergillus niger inulin endopeptidase gene and recombinant Pichia strain for expressing same
03/16/2005CN1594541A Chinese caterpillar fungus and its separating method
03/16/2005CN1594540A Method for making spirulina alga culture solution
03/16/2005CN1594539A Specific strain for degrading organic waste water of medicine production and its construction method
03/16/2005CN1594538A Microbial community and its preparation method and use
03/16/2005CN1594147A Water treatment method for recycling bath sewage using biological active carbon
03/16/2005CN1193096C Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism
03/16/2005CN1193042C C-peptide for the improved production of insulin and insulin analogues
03/15/2005US6867288 Polycystic kidney disease gene
03/15/2005US6867037 High level secretory expression system of intact MK family protein
03/15/2005US6867034 Methods of screening novel agents for use in cancer therapy and prevention
03/15/2005US6867027 RNA polymerase
03/15/2005US6867023 Generating preferential compound in bacterial culture; obtain microorganism, incubate with fatty acid, recover preferential compound
03/15/2005US6867020 Nucleotide sequences coding preferential polypeptides associated with blood formation; for use in treatment of blood disorders
03/15/2005US6867013 Methods of screening for antagonists and agonists of polypeptides having kinase functions
03/15/2005US6867010 Enzyme activity screen with direct substrate reloading
03/15/2005US6867009 Nucleotide sequences coding polypeptide for use the treatment of neuropathic pain
03/15/2005US6866997 Designing a protein which is capable of binding to any predefined nucleic acid sequence
03/15/2005US6866855 Protein for use in the treatment and prevention of bacterial infections
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/10/2005WO2005021777A2 Uses of spatial configuration to modulate protein function
03/10/2005WO2005021770A1 Process for producing succinic acid
03/10/2005WO2005021747A1 Novel vector and utilization of the same
03/10/2005WO2005021742A2 Alcohol production using sonication
03/10/2005WO2005021740A1 Method for detoxification of mycotoxins
03/10/2005WO2005021736A1 A method for preparing t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene
03/10/2005WO2005021735A1 Method for increasing yield of biomass of and/or components of biomass from marine microorganisms
03/10/2005WO2005021722A2 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
03/10/2005WO2005021703A1 Microorganism culturing apparatus and method of inserting bag into culturing apparatus
03/10/2005WO2005021564A1 Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof
03/10/2005WO2005021032A1 Live attenuated aldolase-negative bacterial vaccine
03/10/2005WO2005021031A2 Live attenuated bacterial vaccine
03/10/2005WO2005021030A1 Live attenuated leishmania vaccines
03/10/2005WO2005020924A2 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
03/10/2005WO2005010170A9 Fermentation medium based on a highly hydrolized protein substrate
03/10/2005WO2004101768A3 Recombinant comamonas testosreroni 5-mgam-4d amids and carboxylic acid production
03/10/2005WO2004070351A3 Protein fragment complementation assays for high-throughput and high-content screening
03/10/2005WO2004020621A8 Thermostable ribonuclease h
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005US20050054843 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054722 With halogenated furanones and related 3-haloalkenones; for inhibition of activities and actions of microorganisms, particularly bacteria; for treating bacterial infections, reducing biofilm formation
03/10/2005US20050054103 Using enzyme inhibitor to prevent phosphatidylinositol 3-kinase (PI 3-kinase) activity and expand preferential cell populations; regenerative medicine; tissue engineering; immunotherapy
03/10/2005US20050054099 Matrix derived from whole organ
03/10/2005US20050054086 Bioeractor for use in continous propagation of microorganisms; modular growing tank; propagating bacteria for use in removal of grease from grease traps
03/10/2005US20050054076 Escherichia coli (E. coli) strain capable of producing L-threonine in high yield; expression repression of threonine biosynthesis genes by a metJ gene product is prevented, thereby producing a high concentration of threonine
03/10/2005US20050054067 Process for producing dipeptide,l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase
03/10/2005US20050054066 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
03/10/2005US20050054062 Gene conferring lysozyme insensitivity to Corynebacterium
03/10/2005US20050054061 Using transgenic gramnegative bacteria as bioreactor for fermentation of histidine to be used in medicine, cosmetics and animal feeds
03/10/2005US20050054060 Method for the preparation of an evolved microorganism for the creation or the modification of metabolic pathways
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054038 High level constitutive production of anthrax protective antigen
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050054030 Using methylobacterium as bioremediation tool in biodegradation of nitrogen explosive residues; pollution control
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053991 Propagating cells that exhibits good viability over long periods after desiccation and rehydration; storage stability; genetic engineering and gene transfer
03/10/2005US20050053940 Mutant huntingtin polypeptide for use in identifying modulator for treatment of nervous system disorders
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053933 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
03/10/2005US20050053932 Novel stress-associated genetic products from ashbya gossypii
03/10/2005US20050053927 Rifamycin biosynthesis gene cluster
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053913 Reverse two-hybrid systems
03/10/2005US20050053912 Methods for inducing reversible stasis
03/10/2005US20050053702 Novel protective cultures and their use in the preservation of foodstuffs
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053584 Biocontrol of disease caused by virulent strains of Xylella fastidiosa by cross protection with benign strains of Xylella fastidiosa
03/10/2005US20050053582 Improving shelf life and/or quality of edible products via microorganisms which are defective in their pyruvate metabolism (such as Lactococcus strains which are defective with respect to pyruvate formate lyase and/or lactate dehydrogenase activity); gene overexpression
03/10/2005CA2537151A1 Novel vector and utilization of the same
03/10/2005CA2536675A1 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
03/10/2005CA2536467A1 Method for detoxification of mycotoxins
03/10/2005CA2536067A1 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
03/10/2005CA2535902A1 Uses of spatial configuration to modulate protein function
03/10/2005CA2534579A1 Live attenuated bacterial vaccine